NASDAQ:TRIV TriVascular Technologies (TRIV) Stock Price, News & Analysis → Bible Shocker: Have You Seen Elon Musk’s Miracle? (From InvestorPlace) (Ad) Free TRIV Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$5.87▼$5.8750-Day Range N/A52-Week Range$3.98▼$11.49VolumeN/AAverage Volume18,900 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get TriVascular Technologies alerts: Email Address Ad InvestorPlaceElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. About TriVascular Technologies Stock (NASDAQ:TRIV)Trivascular Technologies, Inc. is a medical device company developing and commercializing technologies to advance minimally invasive treatment of abdominal aortic aneurysms (AAA). The Ovation System, the Company's solution for the treatment of AAA through minimally invasive endovascular aortic repair, or EVAR, is a stent graft platform, providing an alternative to conventional devices. It is designed to specifically address many of the limitations associated with conventional EVAR devices and expand the pool of patients eligible for EVAR. The Company is developing Ovation iX iliac limbs for use with both its Ovation Prime and its Ovation iX and Alto aortic bodies, which are in development. Trivascular is developing Ovation iX aortic bodies for use with both its Ovation Prime and its Ovation iX iliac limbs. The Company is developing an aortic body that together with the iliac limbs makes up the Ovation Alto stent graft.Read More Ad InvestorPlaceElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. TRIV Stock News HeadlinesJanuary 4, 2024 | businesswire.comVensana Capital Strengthens Team with Promotions and Addition of Venture PartnerApril 12, 2023 | marketwatch.com2023-2030 Aortic Endografts Market Size Detailed Report with Downstream Market Analysis | Research by Absolute ReportsMarch 10, 2023 | marketwatch.comAortic Endografts Market Size 2023 - 2030 Market Dynamics, Generate Revenue, the Impact of Covid -19, Foreign Opportunity, Installation.March 3, 2023 | forbes.comWorld Wide TechnologyMarch 3, 2023 | marketwatch.comGlobal Aortic Endografts Market Forecast Will Escalate Rapidly in the Future By VMReportsJanuary 24, 2023 | marketwatch.comEndovascular Aneurysm Repair (EVAR) Market (New Research 2023-2027): Expanding Technologies, Demand and Developments Analysis with Industry GrowthJanuary 23, 2023 | marketwatch.comEndovascular Repair (EVAR) Market 2023 : Future Demand, Emerging Trends and Latest Technology, Forecast Research Report 2028August 19, 2022 | marketwatch.comEndovascular Repair (EVAR) Market 2022 Sales, Revenue, Dynamics, Growth Opportunities, Industry Share, Top Manufacturers, Future Trends till 2028July 13, 2022 | marketwatch.comEndovascular Aneurysm Repair (EVAR) Market Size, Trends, Analysis, Demand, Outlook and Forecast to 2027April 8, 2022 | apnews.comOrthofix Announces New Business Unit PresidentMarch 30, 2022 | marketwatch.comGlobal Aortic Endografts Market 2022 Growth Analysis, Industry Trends, Sales Revenue, Future Development Status and Forecast by 2028March 29, 2022 | marketwatch.comGlobal Endovascular Aneurysm Repair (EVAR) Market 2022 Definitions, Classifications, Applications, Industry Analysis and Forecast by 2028See More Headlines Receive TRIV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TriVascular Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:TRIV CUSIPN/A CIKN/A Webwww.trivascular.com Phone+1-707-5438800FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report TRIV Stock Analysis - Frequently Asked Questions What other stocks do shareholders of TriVascular Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other TriVascular Technologies investors own include Avinger (AVGR), Cardiovascular Systems (CSII), Edwards Lifesciences (EW), NuVasive (NUVA), Endologix (ELGX), ICU Medical (ICUI), Neovasc (NVCN), NxStage Medical (NXTM) and Orthofix Medical (OFIX). This page (NASDAQ:TRIV) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsDems have chosen Biden replacement?Paradigm PressHow Biden has already won 2024Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchProtect Your Bank Account Before It’s Too LateWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TriVascular Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.